Stephen Williams, Associate Chief Medical Officer at The University of Texas Medical Branch, shared on X:
“Wonderful to see global financial implications in bladder cancer care being formally discussed as IBCG26 recommendation.
Amanda Myers discussed value and appropriate management with equal weight and rigor as oncologic outcomes. Outstanding.”
This also can be interesting: Enfortumab Vedotin–Pembrolizumab Improves Survival in Cisplatin-Eligible Bladder Cancer
